Robert Rapaport
Analyst, RTW Investments, LP
Robert is a Healthcare Investment Analyst with over 20 years of diverse industry experience. At RTW Investments, he focuses on medical technology companies, including medical devices, life science tools, and diagnostics.
Prior to joining RTW, Robert was an Analyst at Alger, where he led coverage across a wide range of healthcare subsectors, with a particular focus on medical technology and biotechnology. He also held investment analyst roles at Machaon Capital and Columbus Circle Investors.
Earlier in his career, Robert was a member of the Specialty Pharmaceuticals research team at FTN Equity Capital Management. He also spent several years at Citigroup, where he held multiple roles, including equity research coverage of biotech and life science tools companies, as well as equity trading as a Healthcare Specialist.
Robert earned a Bachelor of Science in Finance from the University of Maryland.
Back to Leadership